Deverra Therapeutics
PrivateLast Round
Crowdfunding
Sep 1, 2024
Est. Valuation
$70.04M
Total Funding Raised
$11.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deverra Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Crowdfunding round in September 2024.
Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies for the treatment of cancer and other life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deverra Therapeutics Comparables
Compare Deverra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indapta Therapeutics | 83% | |
| ExCellThera | 83% | |
| Coeptis Therapeutics Holdings Inc | 82% |
For institutional investors. Book with your work email.
Deverra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Sep 1, 2024 | ||||
| Convertible Debt | Sep 8, 2023 | ||||
| Grant | Jun 8, 2023 | ||||
| Convertible Debt | Dec 28, 2022 | ||||
| Convertible Debt | Mar 22, 2022 | ||||
Debt | Dec 7, 2021 |
For institutional investors. Book with your work email.
Deverra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andy Hill Cancer Research Endowment Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 447% MoM, from 317 to 1.7K.
- Apr 18, 2026
Monthly visitors grew 42% MoM, from 779 to 1.1K.
For institutional investors. Book with your work email.
Deverra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deverra Therapeutics's valuation, stock price, and market status.
Is Deverra Therapeutics a public or private company?
Deverra Therapeutics is a private company.
What is the current stock price of Deverra Therapeutics?
Deverra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Deverra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deverra Therapeutics worth (valuation)?
Deverra Therapeutics's valuation is estimated at $70.0M based on funding round data.
Can I buy Deverra Therapeutics stock?
Deverra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deverra Therapeutics's last funding round?
Deverra Therapeutics's most recent funding round was Crowdfunding on September 1, 2024.
Who are the main investors in Deverra Therapeutics?
Key investors in Deverra Therapeutics include Andy Hill Cancer Research Endowment Fund.
Will Deverra Therapeutics IPO soon?
No public IPO plans have been announced for Deverra Therapeutics.
How can I track Deverra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Deverra Therapeutics's shares on secondary markets.